Children with heart disease have special needs, and pediatric hypertrophic cardiomyopathy presents special challenges. A new study confirms the best approach for effective treatment.
A diagnosis of an enlarged heart in athletes may be a serious medical issue – or just a byproduct of an active lifestyle. The challenge for physicians is differentiating between the two.
Hypertrophic cardiomyopathy (HCM) is a complex type of heart disease that affects one in 500 people. Learn more from a Cleveland Clinic physician during a live webchat Friday, Dec. 7, 2012, at noon (ET).
Ask questions and get answers about heart surgery from a Cleveland Clinic physician during a live webchat Wednesday, Nov. 14, 2012, at noon (ET).
The Miller Family Heart & Vascular Institute and the Hypertrophic Cardiomyopathy Association (HCMA) are hosting a comprehensive program about diagnosis and treatment of HCM.
Learn more, register and join to start asking questions now. They will be answered during the web chat tomorrow, 9/1 from Noon - 1 p.m.